Escalon Medical Corp. (ESMC) Operating margin 2017–2026
Escalon Medical Corp. (ESMC) operating margin by fiscal year — reported operating income divided by reported revenue.
0.4%FY2026 · since FY2017: -5.6% → 0.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 0.4% | -0.8 pp |
| FY2025 | 1.1% | +2.0 pp |
| FY2024 | -0.9% | -4.8 pp |
| FY2023 | 3.9% | +8.3 pp |
| FY2022 | -4.4% | -4.1 pp |
| FY2021 | -0.3% | +14.6 pp |
| FY2020 | -14.9% | -12.3 pp |
| FY2019 | -2.6% | -4.4 pp |
| FY2018 | 1.8% | +7.4 pp |
| FY2017 | -5.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ESMC financial trends
ESMC RevenueESMC Net incomeESMC Net marginESMC Gross profitESMC Gross marginESMC Operating incomeESMC Operating cash flowESMC Free cash flowESMC Capital expendituresESMC Return on equityESMC Stock buybacksESMC Dividends paidESMC Total assetsESMC Total liabilitiesESMC Shareholders’ equityESMC overview →